CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- S-3MEF Other S-3MEF
- 424B5 Offering Prospectus
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Open-market buy Director bought 9,200 shares at $3.41 ($31,350)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $3.15 ($31,499)
- 4 Open-market buy President and CEO bought 15,000 shares at $3.14 ($47,100)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $3.54 ($17,700)
- 4 Open-market buy President and CEO bought 20,000 shares at $3.54 ($70,790)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,188 shares (to pay taxes)
- 8-K Event Other events
- 4 Shares withheld for taxes Director gave up 11,632 shares (to pay taxes)
Page 3 of 74 · 1,466 filings